Skip to main content
Journal cover image

Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.

Publication ,  Journal Article
Mentz, RJ; O'Brien, EC
Published in: J Am Coll Cardiol
July 19, 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

July 19, 2016

Volume

68

Issue

3

Start / End Page

249 / 251

Location

United States

Related Subject Headings

  • Valsartan
  • Tetrazoles
  • Patient Readmission
  • Humans
  • Heart Failure
  • Drug Combinations
  • Cardiovascular System & Hematology
  • Biphenyl Compounds
  • Angiotensin Receptor Antagonists
  • Aminobutyrates
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mentz, R. J., & O’Brien, E. C. (2016). Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions. J Am Coll Cardiol, 68(3), 249–251. https://doi.org/10.1016/j.jacc.2016.05.013
Mentz, Robert J., and Emily C. O’Brien. “Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.J Am Coll Cardiol 68, no. 3 (July 19, 2016): 249–51. https://doi.org/10.1016/j.jacc.2016.05.013.
Mentz, Robert J., and Emily C. O’Brien. “Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.J Am Coll Cardiol, vol. 68, no. 3, July 2016, pp. 249–51. Pubmed, doi:10.1016/j.jacc.2016.05.013.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

July 19, 2016

Volume

68

Issue

3

Start / End Page

249 / 251

Location

United States

Related Subject Headings

  • Valsartan
  • Tetrazoles
  • Patient Readmission
  • Humans
  • Heart Failure
  • Drug Combinations
  • Cardiovascular System & Hematology
  • Biphenyl Compounds
  • Angiotensin Receptor Antagonists
  • Aminobutyrates